Our latest study on the serum-free growth of NK-92 cells for adoptive immunotherapy, led by Dr. Evren Alici’s group at Karolinska Institutet, was published in the journal Cancers as part of a special issue on Natural Killer Cells and Cancer Therapy.

You can reach the paper by following this link.